Sachiko Arai - Kanazawa Univ, Canc Res Inst, Div Med Oncol, Kanazawa, Ishikawa, Japan

基本信息

浏览量：2

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 47 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Targeting WEE1 Enhances the Antitumor Effect of KRAS-mutated Non-Small Cell Lung Cancer Harboring TP53 Mutations

Koji Fukuda,Shinji Takeuchi,Sachiko Arai,Shigeki Nanjo,Shigeki Sato,Hiroshi Kotani,Kenji Kita,Akihiro Nishiyama,Hiroyuki Sakaguchi,Koshiro Ohtsubo,Seiji Yano

CELL REPORTS MEDICINEno. 6 (2024)

引用3浏览0WOS引用

Drug–drug Conjugates of MEK and Akt Inhibitors for RAS-mutant Cancers

Hikaru Fujita,Sachiko Arai,Hiroshi Arakawa, Kana Hamamoto, Toshiyuki Kato, Tsubasa Arai, Nanaka Nitta,Kazuki Hotta, Natsuko Hosokawa, Takako Ohbayashi,Chiaki Takahashi,Yasuhide Inokuma,Ikumi Tamai,Seiji Yano,Munetaka Kunishima,Yoshihiro Watanabe

Bioorganic & Medicinal Chemistry (2024): 117674-117674

引用0浏览0WOS引用

Sup. Figure 1: EGFP-Eluc Gene Transfection Did Not Affect the Sensitivity of KM12SM Cells to Entrectinib. from Foretinib Overcomes Entrectinib Resistance Associated with the NTRK1 G667C Mutation in NTRK1 Fusion–Positive Tumor Cells in a Brain Metastasis Model

Akihiro Nishiyama,Tadaaki Yamada,Kenji Kita,Rong Wang,Sachiko Arai,Koji Fukuda,Azusa Tanimoto,Shinji Takeuchi,Shoichiro Tange,Atsushi Tajima,Noritaka Furuya,Takayoshi Kinoshita,Seiji Yano

openalex（2023）

引用0浏览0引用

Sup. Figure 7: Knockdown of NTRK1 but Not of VEGFR-2 or MET Inhibited the Viability of KM12SM-ER Cells in Vitro. from Foretinib Overcomes Entrectinib Resistance Associated with the NTRK1 G667C Mutation in NTRK1 Fusion–Positive Tumor Cells in a Brain Metastasis Model

Akihiro Nishiyama, Tadaaki Yamada,Kenji Kita,Rong Wang,Sachiko Arai,Koji Fukuda,Azusa Tanimoto,Shinji Takeuchi,Shoichiro Tange, Atsushi Tajima,Noritaka Furuya,Takayoshi Kinoshita,Seiji Yano

openalex（2023）

引用0浏览0引用

Vorinostat Combined with Osimertinib Prompts Transcription of Active BIM Isoform in Cells Which Are Homozygous for the BIM Deletion Polymorphism. from Histone Deacetylase 3 Inhibition Overcomes BIM Deletion Polymorphism–Mediated Osimertinib Resistance in EGFR-Mutant Lung Cancer

Azusa Tanimoto,Shinji Takeuchi,Sachiko Arai,Koji Fukuda, Tadaaki Yamada,Xavier Roca,S. Tiong Ong,Seiji Yano

openalex（2023）

引用0浏览0引用

Figure S5 from Distribution and Activity of Lenvatinib in Brain Tumor Models of Human Anaplastic Thyroid Cancer Cells in Severe Combined Immune Deficient Mice

Rong Wang, Tadaaki Yamada,Sachiko Arai,Koji Fukuda,Hirokazu Taniguchi,Azusa Tanimoto,Akihiro Nishiyama,Shinji Takeuchi,Kaname Yamashita,Koshiro Ohtsubo, Junji Matsui,Naoyoshi Onoda,Eishu Hirata,Shu Taira,Seiji Yano

openalex（2023）

引用0浏览0引用

Figure S4 from Distribution and Activity of Lenvatinib in Brain Tumor Models of Human Anaplastic Thyroid Cancer Cells in Severe Combined Immune Deficient Mice

openalex（2023）

引用0浏览0引用

Figure S6 from Distribution and Activity of Lenvatinib in Brain Tumor Models of Human Anaplastic Thyroid Cancer Cells in Severe Combined Immune Deficient Mice

Rong Wang,Tadaaki Yamada,Sachiko Arai,Koji Fukuda,Hirokazu Taniguchi,Azusa Tanimoto,Akihiro Nishiyama,Shinji Takeuchi,Kaname Yamashita,Koshiro Ohtsubo,Junji Matsui,Naoyoshi Onoda,Eishu Hirata,Shu Taira,Seiji Yano

openalex（2023）

引用0浏览0引用

Figure S3 from Distribution and Activity of Lenvatinib in Brain Tumor Models of Human Anaplastic Thyroid Cancer Cells in Severe Combined Immune Deficient Mice

openalex（2023）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn